(Huma-zon Promedic, Germany) on secondary wound healing in 50 patients with type 2 diabetes and diabetic foot ulcers by using an immuno-histochemical analysis of VEGF and TGF-β in two groups: oxygen-ozone therapy (test) and no treatment (control). The gene discussed is TGFB1; the disease is diabetic foot.